Controlling Nutritional Status (CONUT) Score is Associated with Overall Survival in Patients with Hepatocellular Carcinoma Treated with Conventional Transcatheter Arterial Chemoembolization: A Propensity Score Matched Analysis
- Zhuofan Deng 1, Wenfeng Zhang 1, Junwei Peng 2, Linxiao Gao 1, Chunyu Zhang 1, Kai Lei 1, Jianping Gong 1, Bin Xiong 3
- Zhuofan Deng 1, Wenfeng Zhang 1, Junwei Peng 2
- 1Department of Hepatobiliary Surgery, The Second Affiliated Hospital of Chongqing Medical University, Chongqing, China.
- 2Department of Pediatric Surgical Oncology, Children's Hospital of Chongqing Medical University, Chongqing, China.
- 3Department of Hepatobiliary Surgery, The Second Affiliated Hospital of Chongqing Medical University, Chongqing, China. 304370@hospital.cqmu.edu.cn.
- 0Department of Hepatobiliary Surgery, The Second Affiliated Hospital of Chongqing Medical University, Chongqing, China.
Related Experiment Videos
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
View abstract on PubMed
Summary
This summary is machine-generated.A high Controlling Nutritional Status (CONUT) score indicates a poorer prognosis for overall survival in hepatocellular carcinoma patients undergoing chemoembolization. This finding highlights CONUT score as a valuable prognostic factor.
Area Of Science
- Hepatology and Oncology
- Interventional Radiology
- Nutritional Assessment
Background
- Hepatocellular carcinoma (HCC) is a primary liver malignancy with complex treatment strategies.
- Conventional transcatheter arterial chemoembolization (cTACE) is a standard treatment for unresectable HCC.
- Prognostic markers are crucial for tailoring treatment and predicting outcomes in HCC patients.
Purpose Of The Study
- To investigate the prognostic significance of the Controlling Nutritional Status (CONUT) score in patients with HCC treated with cTACE.
- To determine if the CONUT score can predict overall survival (OS) and progression-free survival (PFS) in this patient cohort.
Main Methods
- Retrospective analysis of 936 HCC patients treated with cTACE from 2012-2018.
- Propensity score matching (PSM) to balance baseline characteristics between low and high CONUT score groups.
- Kaplan-Meier survival analysis, log-rank tests, and Cox proportional hazard models to assess OS and PFS.
Main Results
- After PSM, a high CONUT score (≥4) was associated with significantly poorer median OS (17.0 months) compared to a low CONUT score (≤3) (22.2 months, P=0.014).
- No significant difference in PFS was observed between the groups (P=0.121).
- Cox regression identified a high CONUT score as an independent risk factor for OS (HR=1.361, P=0.022).
Conclusions
- The CONUT score is a valuable and independent prognostic factor for overall survival in HCC patients undergoing cTACE.
- A high CONUT score predicts worse outcomes, suggesting its utility in clinical decision-making and patient stratification.
Related Experiment Videos
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.

